Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Dirnhofer

Showing results (1-10 of 110) with videos related to

Pageof 11
Sort By:
Virchows Archiv : an International Journal of Pathology|February 24, 2019
Cancer immunology, inflammation, and tolerance: an introductionStefan Dirnhofer, Alfred Zippelius
Pathologie (Heidelberg, Germany)|August 4, 2022
[Differential diagnosis of reactive cytopenias]Thomas Menter, Stefan Dirnhofer, Alexandar Tzankov
Hematological Oncology|June 15, 2025
Non-Clonal Lymphoproliferative DiseasesStefan Dirnhofer, Yoshito Nishimura, Angela Dispenzieri
Therapeutische Umschau. Revue Therapeutique|September 28, 2017
Thomas Menter, Alexandar Tzankov, Stefan Dirnhofer
Hematological Oncology|October 26, 2020
The tumor microenvironment of lymphomas: Insights into the potential role and modes of actions of checkpoint inhibitorsThomas Menter, Alexandar Tzankov, Stefan Dirnhofer
Journal of Clinical Pathology|March 1, 2019
Transformation of a splenic marginal zone lymphoma into classic Hodgkin lymphomaThomas Menter, Stefan Dirnhofer, Alexandar Tzankov
Virchows Archiv : an International Journal of Pathology|August 26, 2018
Immune tumor board: integral part in the multidisciplinary management of cancer patients treated with cancer immunotherapyHeinz Läubli, Stefan Dirnhofer, Alfred Zippelius
Pathologie (Heidelberg, Germany)|March 15, 2023
[Classification of aggressive B-cell lymphomas : News and open questions]Andreas Rosenwald, Thomas Menter, Stefan Dirnhofer
Annals of Hematology|May 19, 2026
Pseudo-Richter transformation in a patient with chronic lymphocytic leukemia after cessation of fixed duration venetoclax/ibrutinib treatmentRaphael Battegay, Dominik Heim, Stefan Dirnhofer
Therapeutische Umschau. Revue Therapeutique|January 9, 2020
[Reactive Lymphadenopathies]Alfonso Vallejo, Thomas Menter, Alexandar Tzankov, et al.
Pageof 11

Showing results (1-10 of 110) with videos related to

Sort By:
Pageof 11
Virchows Archiv : an International Journal of Pathology|February 24, 2019
Cancer immunology, inflammation, and tolerance: an introductionStefan Dirnhofer, Alfred Zippelius
Pathologie (Heidelberg, Germany)|August 4, 2022
[Differential diagnosis of reactive cytopenias]Thomas Menter, Stefan Dirnhofer, Alexandar Tzankov
Hematological Oncology|June 15, 2025
Non-Clonal Lymphoproliferative DiseasesStefan Dirnhofer, Yoshito Nishimura, Angela Dispenzieri
Therapeutische Umschau. Revue Therapeutique|September 28, 2017
Thomas Menter, Alexandar Tzankov, Stefan Dirnhofer
Hematological Oncology|October 26, 2020
The tumor microenvironment of lymphomas: Insights into the potential role and modes of actions of checkpoint inhibitorsThomas Menter, Alexandar Tzankov, Stefan Dirnhofer
Journal of Clinical Pathology|March 1, 2019
Transformation of a splenic marginal zone lymphoma into classic Hodgkin lymphomaThomas Menter, Stefan Dirnhofer, Alexandar Tzankov
Virchows Archiv : an International Journal of Pathology|August 26, 2018
Immune tumor board: integral part in the multidisciplinary management of cancer patients treated with cancer immunotherapyHeinz Läubli, Stefan Dirnhofer, Alfred Zippelius
Pathologie (Heidelberg, Germany)|March 15, 2023
[Classification of aggressive B-cell lymphomas : News and open questions]Andreas Rosenwald, Thomas Menter, Stefan Dirnhofer
Annals of Hematology|May 19, 2026
Pseudo-Richter transformation in a patient with chronic lymphocytic leukemia after cessation of fixed duration venetoclax/ibrutinib treatmentRaphael Battegay, Dominik Heim, Stefan Dirnhofer
Therapeutische Umschau. Revue Therapeutique|January 9, 2020
[Reactive Lymphadenopathies]Alfonso Vallejo, Thomas Menter, Alexandar Tzankov, et al.
Pageof 11